2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

GenEdit Competitors or Alternatives

GenEdit's top competitors include Casma, Caribou and Intellia Therapeutics.

Unlock 28 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

GenEdit's company profile

Lee Kunwoo

Co-Founder & CEO

70/100
25 - 100
$34.5M
$100K - 5M
  • $34.5M
    $100K - 5M
  • 25 - 100
    $34.5M
  • $100K - 5M
  • 70/100
  • 25 - 100
  • $34.5M
  • $100K - 5M
View ProfileView
1
GenEdit's Competitor - Casma logo

Frank Gentile

President & CEO

83/100
25 - 100
$154.9M
$100K - 5M
  • $154.9M
    $100K - 5M
  • 25 - 100
    $154.9M
  • $100K - 5M
  • 83/100
  • 25 - 100
  • $154.9M
  • $100K - 5M
View ProfileView
2
GenEdit's Competitor - Caribou logo

Rachel Haurwitz

President & CEO

90/100
100
$486.5M
$9.1M
  • $486.5M
    $9.1M
  • 100
    $486.5M
  • $9.1M
  • 90/100
  • 100
  • $486.5M
  • $9.1M
View ProfileView
3
GenEdit's Competitor - Intellia Therapeutics logo

John Leonard

President & CEO

81/100
600
$883.6M
$57.5M
  • $883.6M
    $57.5M
  • 600
    $883.6M
  • $57.5M
  • 81/100
  • 600
  • $883.6M
  • $57.5M
View ProfileView
4
GenEdit's Competitor - AVROBIO logo

Erik Ostrowski

Interim-CEO

82/100
25 - 100
$167.2M
$100K - 5M
  • $167.2M
    $100K - 5M
  • 25 - 100
    $167.2M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $167.2M
  • $100K - 5M
View ProfileView
5
GenEdit's Competitor - Roivant logo

Matthew Gline

CEO

82/100
860
$2.1B
$23.2M
  • $2.1B
    $23.2M
  • 860
    $2.1B
  • $23.2M
  • 82/100
  • 860
  • $2.1B
  • $23.2M
View ProfileView
GenEdit's top 31 competitors are Casma, Caribou, Intellia Therapeutics, Ultragenyx, AVROBIO, Roivant, Clementia Pharmaceuticals, Inc., Immune Design, Juno Therapeutics, Espero Biopharma, Altor BioScience, Denovo Biopharma, Kallyope, Aprea, Idorsia, Sutro Biopharma, Healx, bluebird bio, InterMune, Arrowhead, Cardior, Alnylam, Agenus, HighPoint Solutions, Strongbridge Biopharma, aTyr Pharma, Acerus, Liberty University, NeRRe, TESARO and Heron. Together they have raised over 18.4B between their estimated 23.8K employees. GenEdit's revenue is the ranked 28th among it's top 10 competitors. The top 10 competitors average 231M. GenEdit has 30 employees and is ranked 27th among it's top 10 competitors. The top 10 competitors average 744.

GenEdit VS Casma

Casma is GenEdit's biggest rival. Casma was founded in Cambridge, Massachusetts} in 2018. Like GenEdit, Casma also competes in the Biotechnology sector. Compared to GenEdit, Casma generates $1.9M more revenue.

GenEdit VS Caribou

Caribou is GenEdit's #2 rival. Caribou's headquarters is in Berkeley, California, and was founded in 2011. Like GenEdit, Caribou also competes in the Pharmaceuticals & Biotechnology space. Caribou generates 434% of GenEdit's revenue.

GenEdit VS Intellia Therapeutics

Intellia Therapeutics is GenEdit's #3 competitor. Intellia Therapeutics was founded in 2014 in Cambridge, Massachusetts. Like GenEdit, Intellia Therapeutics also works within the Biotechnology sector. Intellia Therapeutics generates $55.4M more revenue than GenEdit.

Looking for similar companies to GenEdit?

Similar Companies

Biotechnology companies in San Francisco

See 325 companies 
Biotechnology companies in San Francisco Bay Area

See 1,320 companies 
Pharmaceuticals & Biotechnology companies in San Francisco

See 387 companies 
Pharmaceuticals & Biotechnology companies in San Francisco Bay Area

See 1,673 companies 
Biotechnology companies in California

See 3,098 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,188 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,525 companies 
Biotechnology companies with employees in 25-100 range

See 5,179 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100K-5.0M range

See 6,027 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for GenEdit and GenEdit's Competitors

November 5, 2025Benzinga
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneeri...
November 5, 2025Owler
Ultragenyx’s Trailing Twelve Months revenue changed from $610.16M in Jun 2025 to $630.60M in Sep 2025 increasing 3.3% in this time period....
November 5, 2025centralcharts
New analysis confirms reductions in blood pressure and albuminuria by aprocitentan in patients with true resistant hypertension and high cardiovascular...
November 5, 2025Seeking Alpha

Frequently Asked Questions about GenEdit

  1. Who are GenEdit's top competitors?

    GenEdit's top 3 competitors are Casma, Caribou, Intellia Therapeutics.

  2. Who is similar to GenEdit?

    Casma is the most similar to GenEdit. Caribou and Intellia Therapeutics are also similar to GenEdit.

  1. Are GenEdit and Casma competitors?

    Yes, Casma is one of GenEdit’s top competitors.